Ensysce Biosciences, Inc. (ENSC, ENSCW)
CIK 1716947 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ensysce Biosciences, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 25, 2026 | 8-K | 0001493152-26-040080 |
| Aug 24, 2026 | 8-K | 0001493152-26-039898 |
| Aug 20, 2026 | D | 0001493152-26-039439 |
| Aug 18, 2026 | SCHEDULE 13D/A | 0001493152-26-038943 |
| Aug 18, 2026 | 4 | 0001493152-26-038866 |
| Aug 13, 2026 | 8-K | 0001493152-26-037794 |
| Aug 13, 2026 | 10-Q | 0001493152-26-037817 |
| Aug 10, 2026 | 3 | 0001493152-26-036856 |
| Aug 6, 2026 | 8-K/A | 0001493152-26-036326 |
| Aug 6, 2026 | 8-K | 0001493152-26-036268 |
| Jul 15, 2026 | 8-K | 0001493152-26-033360 |
| Jun 26, 2026 | EFFECT | 9999999995-26-002133 |
| Jun 4, 2026 | S-3 | 0001493152-26-027289 |
| May 22, 2026 | 8-K | 0001493152-26-025061 |
| May 15, 2026 | 8-K | 0001493152-26-023810 |
| May 15, 2026 | 10-Q | 0001493152-26-023811 |
| Apr 30, 2026 | S-8 | 0001493152-26-020504 |
| Apr 15, 2026 | EFFECT | 9999999995-26-001203 |
| Apr 9, 2026 | S-3 | 0001493152-26-015763 |
| Apr 8, 2026 | 8-K | 0001493152-26-015602 |
| Apr 3, 2026 | 8-K | 0001493152-26-015139 |
| Mar 30, 2026 | 10-K | 0001493152-26-013633 |
| Mar 30, 2026 | 8-K | 0001493152-26-013314 |
| Mar 30, 2026 | 8-K | 0001493152-26-013622 |
| Mar 23, 2026 | 8-K | 0001493152-26-012062 |